Home539871 • BOM
add
Thyrocare Technologies Ltd
Previous close
₹970.35
Day range
₹945.60 - ₹975.90
Year range
₹545.05 - ₹1,002.00
Market cap
50.65B INR
Avg Volume
6.71K
P/E ratio
61.01
Dividend yield
1.88%
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 1.77B | 19.84% |
Operating expense | 616.60M | 22.27% |
Net income | 266.70M | 31.12% |
Net profit margin | 15.04 | 9.46% |
Earnings per share | 4.98 | — |
EBITDA | 474.35M | 27.82% |
Effective tax rate | 28.15% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.38B | 38.47% |
Total assets | 5.97B | 0.74% |
Total liabilities | 1.08B | 3.20% |
Total equity | 4.89B | — |
Shares outstanding | 53.45M | — |
Price to book | 10.62 | — |
Return on assets | — | — |
Return on capital | 16.35% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 266.70M | 31.12% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Thyrocare Technologies Limited is an Indian multinational chain of diagnostic and preventive care laboratories, headquartered in Navi Mumbai. As of 2021, the company has a total of 1,122 outlets and collection centers across India and parts of Nepal, Bangladesh and the Middle East.
On 26 June 2021, Indian e-pharmacy and online healthcare aggregator PharmEasy's parent API Holdings acquired a 66.1% controlling stake in Thyrocare, making Thyrocare the first Indian listed company to be acquired by a startup. Wikipedia
Founded
1996
Headquarters
Website
Employees
1,693
